[1] Ghouri YA,Mian I,Rowe JH. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. J Carcinog, 2017, 16: 1.
[2] Goh GB,Chang PE,Tan CK. Changing epidemiology of hepatocellular carcinoma in Asia. Best Pract Res Clin Gastroenterol, 2015, 29: 919-928.
[3] Vannini I,Fanini F,Fabbri M. Emerging roles of microRNAs in cancer. Curr Opin Genet Dev, 2018,48:128-133.
[4] Kalogianni DP,Kalligosfyri PM,Kyriakou IK,et al. Advances in microRNA analysis. Anal Bioanal Chem, 2017, doi:10.1007/s00216-017-0632-z.
[5] Qadir MI,Rizvi SZ. miRNA in hepatocellular carcinoma: pathogenesis and therapeutic approaches. Crit Rev Eukaryot Gene Expr, 2017, 27: 355-361.
[6] Sulas P,Di Tommaso L,Novello C,et al. A large set of miRNAs is dysregulated since the earliest steps of human hepatocellular carcinoma development. Am J Pathol, 2018,188: 785-794.
[7] Li H,Chen H,Wang H,et al. MicroRNA-374a promotes hepatocellular carcinoma cell proliferation by targeting Mitogen-Inducible Gene-6 (MIG-6). Oncol Res, 2017, DOI: 10.3727/096504017x15000784459799.
[8] Chen G,Wang D,Zhao X,et al. miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3beta-involved Wnt/beta-catenin signaling. Cancer Cell Int, 2017, 17: 118.
[9] Liu L,Cai X,Liu E,et al. MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4. Oncotarget, 2017, 8: 68263-68269.
[10] Yu Z,Lin X,Tian M,et al. microRNA196b promotes cell migration and invasion by targeting FOXP2 in hepatocellular carcinoma. Oncol Rep, 2018, 39: 731-738.
[11] Wang L,Wu J,Xie C. miR-92a promotes hepatocellular carcinoma cells proliferation and invasion by FOXA2 targeting. Iran J Basic Med Sci, 2017, 20: 783-790.
[12] Chen Q,Yin D,Zhang Y,et al. MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis. Cell Death Dis, 2017, 8: e2906.
[13] Xue H,Tian GY. MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23. Arch Biochem Biophys, 2018, 637: 48-55.
[14] Zhang R,Zhang LJ,Yang ML,et al. Potential role of microRNA2233p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics. Mol Med Rep, 2018, 17: 2211-2228.
[15] Liang HW,Yang X,Wen DY,et al. Utility of miR133a3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, metaanalysis and bioinformatics. Mol Med Rep, 2018, 17: 1469-1484.
[16] Wu XM,Xi ZF,Liao P,et al. Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1. Oncotarget, 2017, 8: 81235-81249.
[17] Liang HW,Ye ZH,Yin SY,et al. A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma. Onco Targets Ther, 2017, 10: 3405-3419.
[18] Ali HEA,Abdel Hameed R,Effat H,et al. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma. Clin Res Hepatol Gastroenterol, 2017, 41: e51-e62.
[19] Shi M,Jiang Y,Yang L,et al. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma. J Cell Biochem, 2017, doi: 10.1002/jcb.26650.
[20] Liu X,Yang L,Tu J,et al. microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma. Oncotarget, 2017, 8: 87737-87749.
[21] Li Y,Li Y,Chen Y,et al. MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis. Cancer Cell Int, 2017, 17: 102.
[22] Shimagaki T,Yoshizumi T,Harimoto N,et al. MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection. Hepatol Res, 2018, 48: 313-321.
[23] Dietrich P,Koch A,Fritz V,et al. Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance. Gut, 2017, DOI: 10.1136/gutjnl-2017-315402.
[24] Yu S,Jing L,Yin XR,et al. MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP. Oncotarget, 2017, 8: 99757-99771.
[25] Hu D,Shen D,Zhang M,et al. MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma. Am J Cancer Res, 2017, 7: 2070-2080.
[26] Wang Z,Song D,Huang P. MicroRNA340 inhibits tumor cell proliferation, migration and invasion, and induces apoptosis in hepatocellular carcinoma. Mol Med Rep, 2017, 16: 7649-7656.
[27] Shao P,Qu WK,Wang CY,et al. MicroRNA-205-5p regulates the chemotherapeutic resistance of hepatocellular carcinoma cells by targeting PTEN/JNK/ANXA3 pathway. Am J Transl Res, 2017, 9: 4300-4307.
[28] Zhao Y,Qi X,Chen J,et al. The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma. Cancer Lett, 2017, 408: 102-111.
[29] Kudo M. Systemic Therapy for hepatocellular carcinoma: 2017 update. Oncology, 2017, 93 Suppl 1: 135-146.
[30] Kabir TD,Ganda C,Brown RM,et al. A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma. Hepatology, 2018, 67: 216-231. |
